Q4 2021 Alaunos Therapeutics Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Alaunos Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call. (Operator Instructions)
I would now like to turn the call over to your host, Alex Lobo, Stern Investor Relations. You may begin.
Good morning, and welcome to Alaunos Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call and Audio Webcast. With me today are Kevin Boyle Senior, Alaunos Therapeutics' Chief Executive Officer; Drew Deniger, Vice President of Research and Development; and Mike Wong, our Vice President of Finance.
Earlier this morning, Alaunos issued a press release announcing financial results for the 3 months and full year ended December 31, 2021. We encourage everyone to read today's press release as well as the Alaunos Annual Report on Form 10-K for the year ended December 31, 2021, which was filed this morning with the SEC.
The company's press release and annual report will also be available on the Alaunos website at alaunos.com. In
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |